What the Top 10 Biopharma CEOs are Making Published: Jul 25, 2012 #10. Merck & Co. Kenneth C. Frazier, Chairman, President, and CEO 2011 Compensation: $13,347,652 2010 Compensation: $9,439,632 % Change: 41.1% Related links Genetic Engineering & Biotechnology News This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news